Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Acorda Therapeutics
(NQ:
ACOR
)
13.21
+1.30 (+10.92%)
Streaming Delayed Price
Updated: 3:13 PM EDT, Mar 28, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Acorda Therapeutics
< Previous
1
2
3
4
5
6
7
Next >
Acorda Fourth Quarter/Year End 2023 Update: Webcast/Conference Call Scheduled for April 1, 2024
March 25, 2024
From
Acorda Therapeutics
Via
Business Wire
Acorda Therapeutics to Regain Global Commercialization Rights to FAMPYRA® by January 2025
January 11, 2024
From
Acorda Therapeutics
Via
Business Wire
A Look Into Healthcare Sector Value Stocks
November 20, 2023
Via
Benzinga
Acorda Therapeutics Reports Third Quarter 2023 Financial Results
November 13, 2023
From
Acorda Therapeutics
Via
Business Wire
Earnings Scheduled For November 13, 2023
November 13, 2023
Companies Reporting Before The Bell • Sohu.com (NASDAQ:SOHU) is expected to report earnings for its third quarter. • Dixie Gr (NASDAQ:DXYN) is estimated to report earnings for its third quarter.
Via
Benzinga
Acorda Third Quarter 2023 Update: Webcast/Conference Call Scheduled for November 13, 2023
November 06, 2023
From
Acorda Therapeutics
Via
Business Wire
Acorda Therapeutics Announces Biopas Laboratories Submission to Regulatory Agencies in Six Latin American Countries for Approval of INBRIJA®
November 06, 2023
From
Acorda Therapeutics
Via
Business Wire
Acorda Therapeutics Inc. (NASDAQ: ACOR) Leading the Way in Thursday Trading Based on Percentage Gain
October 05, 2023
Via
Investor Brand Network
12 Health Care Stocks Moving In Wednesday's After-Market Session
October 04, 2023
Via
Benzinga
Overview Of Value Stocks In The Healthcare Sector
September 18, 2023
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
August 30, 2023
Via
Benzinga
5 Value Stocks To Watch In The Healthcare Sector
August 21, 2023
Via
Benzinga
Acorda Therapeutics Reports Second Quarter 2023 Financial Results
August 08, 2023
From
Acorda Therapeutics
Via
Business Wire
Acorda Therapeutics Announces Launch of New INBRIJA® Campaign: “For The Fighters™”
August 02, 2023
From
Acorda Therapeutics
Via
Business Wire
Acorda Second Quarter 2023 Update: Webcast/Conference Call Scheduled for August 8, 2023
August 01, 2023
From
Acorda Therapeutics
Via
Business Wire
Tom Burns Elected to the Acorda Therapeutics Board of Directors
June 28, 2023
From
Acorda Therapeutics
Via
Business Wire
Acorda Therapeutics Regains Compliance with Nasdaq Minimum Bid Price Requirement
June 26, 2023
From
Acorda Therapeutics
Via
Business Wire
Why Semtech Shares Are Trading Higher By 25%; Here Are 20 Stocks Moving Premarket
June 08, 2023
Gainers Airspan Networks Holdings Inc. (NYSE: MIMO) shares rose 50.5% to $0.20 in pre-market trading after dropping 5% on Wednesday.
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
June 08, 2023
Pre-market stock movers are a hot topic with traders on Thursday as we go over the shares seeing the biggest movements this morning.
Via
InvestorPlace
Acorda Therapeutics Announces Completion of 1-for-20 Reverse Stock Split
June 02, 2023
From
Acorda Therapeutics
Via
Business Wire
Acorda Therapeutics to Conduct 1-for-20 Reverse Stock Split
May 31, 2023
From
Acorda Therapeutics
Via
Business Wire
Acorda Therapeutics CEO Ron Cohen, M.D., to Hold Virtual Company Presentation and Q&A
May 30, 2023
From
Acorda Therapeutics
Via
Business Wire
Week In Review: BlissBio Announces Potential $2 Billion Deal With Eisai For HER2 ADC
May 13, 2023
Bliss Biopharma may out-license global rights for its HER2 ADC to Eisai Pharma in a deal with a potential value of $2 billion. Also, Junshi Bio out-licensed regional rights for its anti-PD-1 mAb to Dr....
Via
Talk Markets
Acorda Therapeutics Reports First Quarter 2023 Financial Results
May 11, 2023
From
Acorda Therapeutics
Via
Business Wire
3 Penny Stocks to Avoid as Interest Rates Rise in 2023
May 11, 2023
This article reveals the worst penny stocks to invest in for 2023, amid rising interest rates and a deteriorating macro environment.
Via
InvestorPlace
Acorda Therapeutics to Make June 2023 $6.2 Million Interest Payment on Secured Debt in Cash
May 10, 2023
From
Acorda Therapeutics
Via
Business Wire
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
May 09, 2023
Via
Benzinga
Global Alzheimer’s Disease Diagnostics & Therapeutics Market Expected to Reach $9.6 Billion by 2027
May 09, 2023
Palm Beach, FL – May 9, 2023 – FinancialNewsMedia.com News Commentary – Alzheimer’s disease (AD) is a progressive and neurodegenerative disorder that attacks the brain’s nerve cells or neurons, which...
Via
FinancialNewsMedia
Topics
Intellectual Property
Exposures
Intellectual Property
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
May 09, 2023
We're starting off the day with the biggest pre-market stock movers traders will want to keep in mind while trading on Tuesday!
Via
InvestorPlace
12 Health Care Stocks Moving In Monday's Intraday Session
May 08, 2023
Via
Benzinga
< Previous
1
2
3
4
5
6
7
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.